|
CAMK2D expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.79389999999113E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.70660000000345E-05 |
| Normal-vs-Stage2 |
8.260600E-03 |
| Normal-vs-Stage3 |
4.847600E-01 |
| Normal-vs-Stage4 |
1.967200E-01 |
| Stage1-vs-Stage2 |
6.589400E-01 |
| Stage1-vs-Stage3 |
1.030650E-01 |
| Stage1-vs-Stage4 |
9.717000E-01 |
| Stage2-vs-Stage3 |
8.717800E-02 |
| Stage2-vs-Stage4 |
7.400600E-01 |
| Stage3-vs-Stage4 |
3.402800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.50612999999522E-05 |
| Normal-vs-AfricanAmerican |
1.164610E-03 |
| Normal-vs-Asian |
8.100600E-01 |
| Caucasian-vs-AfricanAmerican |
5.057400E-01 |
| Caucasian-vs-Asian |
1.573980E-01 |
| AfricanAmerican-vs-Asian |
1.964600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.98649999999523E-05 |
| Normal-vs-Female |
3.363900E-04 |
| Male-vs-Female |
4.261800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.570400E-02 |
| Normal-vs-Extreme_Weight |
6.006500E-04 |
| Normal-vs-Obese |
1.991800E-04 |
| Normal-vs-Extreme_Obese |
7.020000E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.796800E-01 |
| Normal_Weight-vs-Obese |
3.874800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.099000E-01 |
| Extreme_Weight-vs-Obese |
7.957000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.566200E-01 |
| Obese-vs-Extreme_Obese |
9.517000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.425600E-02 |
| Normal-vs-Age(41-60Yrs) |
2.85369999963869E-07 |
| Normal-vs-Age(61-80Yrs) |
3.340200E-03 |
| Normal-vs-Age(81-100Yrs) |
1.314200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.107600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.422600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.831400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.859900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.037600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.190800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.80639999519872E-08 |
| Normal-VS-Type2 PRCC |
1.702370E-01 |
| Normal-VS-KIRP CIMP |
9.901400E-01 |
| Normal-VS-Unclassified PRCC |
1.627720E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.724300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.210100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.271400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.706200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.024800E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.649600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.571800E-02 |
| Normal-vs-N1 |
8.832400E-02 |
| Normal-vs-N2 |
5.982600E-04 |
| N0-vs-N1 |
5.056200E-01 |
| N0-vs-N2 |
1.179190E-01 |
| N1-vs-N2 |
3.795600E-01 |
|
|
